CYBA rs4673: Understanding the p22phox Variant and Cardiovascular Risk
The rs4673 variant is a genetic change located in the CYBA gene, which provides instructions for making a protein subunit called p22phox. This variant has been studied for its potential role in influencing oxidative stress levels and its association with cardiovascular health, though research findings remain mixed across different populations.
What each genotype means
Typical enzyme function
This genotype represents the most common form of the CYBA gene at this position. Research indicates this version of the p22phox subunit is associated with standard superoxide production levels in the body.
This is the most frequent genotype observed in most global populations.
Typical enzyme function
Carrying one copy of the T allele, also known as the H72Y variant, does not typically result in a significant deviation from normal enzyme activity. Studies have not consistently linked this heterozygous state to major health outcomes.
This genotype is commonly found in individuals of European ancestry, reflecting the high prevalence of the T allele.
Varied cardiovascular risk profile
This genotype, sometimes referred to as the 242T variant, has been studied for its potential role in influencing superoxide production and coronary artery disease risk. Evidence remains conflicting, with some studies suggesting an association that may depend heavily on an individual's specific ethnic background.
This genotype is present in a significant portion of the population, particularly among those of European descent.
What is the rs4673 Variant?
The rs4673 variant, often referred to in scientific literature as C242T or His72Tyr, is a single nucleotide polymorphism (SNP) located within the CYBA gene on chromosome 16. This specific change involves the substitution of one DNA building block for another, which can lead to a change in the amino acid sequence of the resulting protein. Specifically, it results in a histidine-to-tyrosine substitution at position 72 of the p22phox protein. Because this change occurs in a functional domain of the protein, researchers have long investigated whether it alters the protein's ability to participate in cellular processes. It is important to note that while this variant is frequently discussed in the context of cardiovascular research, it is just one of many variations that exist within the human genome, and its presence does not guarantee any specific health outcome.
The Role of the CYBA Gene
The CYBA gene encodes the p22phox protein, which is a critical component of the NADPH oxidase enzyme complex. NADPH oxidases are responsible for producing reactive oxygen species (ROS), which are molecules that play a dual role in the body. While ROS are essential for normal immune function—helping white blood cells destroy invading pathogens—they can also contribute to oxidative stress if produced in excess. The p22phox subunit acts as a structural anchor for the enzyme complex, and its proper function is necessary for the complex to generate superoxide. Because of this central role in oxidative metabolism, scientists have hypothesized that variations in the CYBA gene might influence how efficiently these enzymes operate in the vasculature, potentially impacting the health of blood vessels and the development of conditions like atherosclerosis or hypertension.
Research and Evidence Strength
The evidence linking rs4673 to health outcomes is considered limited and often inconsistent. Numerous studies have explored whether the T allele of this variant is associated with a higher or lower risk of coronary artery disease, but results vary significantly depending on the population studied. Some research suggests that the T allele might be associated with reduced vascular NADPH oxidase activity, while other studies have reported conflicting findings regarding its impact on disease risk. Furthermore, meta-analyses have highlighted that the direction of the effect—whether the variant is protective or a risk factor—may differ between ethnic groups. Because of these discrepancies, the scientific community has not reached a consensus on the clinical significance of this variant. It is best viewed as a subject of ongoing academic investigation rather than a definitive marker for predicting individual health risks.
What You Can Do With This Information
Genetic information like the rs4673 genotype is complex and should be interpreted with caution. Because the association between this variant and health traits is not well-established or consistent, it is not currently used in routine clinical practice to diagnose or predict cardiovascular disease. If you have received results regarding this variant from a genetic test, it is important to remember that your overall health is influenced by a combination of many genetic factors, lifestyle choices, and environmental exposures. You cannot use this information to make medical decisions or change your health regimen on your own. If you have concerns about your cardiovascular health or family history, the most effective approach is to consult with a healthcare professional or a genetic counselor. They can help you understand your overall risk profile based on validated clinical markers rather than focusing on a single, inconclusive genetic variant.
How common is this variant?
The minor allele frequency for rs4673 typically ranges between 0.30 and 0.40 in European populations, though frequencies can vary significantly across different global ancestries.
Frequently asked questions
Is rs4673 a cause of heart disease?
No, rs4673 is not considered a direct cause of heart disease. While it has been studied for potential associations with cardiovascular risk, the evidence is inconsistent and does not support using it as a diagnostic tool.
Should I be worried if I have the T/T genotype?
There is no reason to be worried based on this genotype alone. Genetic variants are common, and the impact of rs4673 is not well-defined or clinically significant for individual health management.
Does this variant affect how I should take my medication?
There is no evidence that rs4673 dictates how you should take medications. Always discuss your medication dosing and any health concerns with your clinician or pharmacist.
Where can I find more information about my specific genotype?
If you have questions about your genetic results, the best resource is a certified genetic counselor or your primary care physician. They can provide context based on your personal and family medical history.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4673?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29